Richard S. Levy

Filings by Richard S. Levy span 5 companies, the busiest being Madrigal Pharmaceuticals, Inc., Kiniksa Pharmaceuticals International, plc and Protara Therapeutics, Inc. The record holds 47 filings, for trades running from 6 January 2016 to 1 August 2026.

The open-market side counts 24 purchases for €279k alongside 1 sale for €373k. The net balance comes to €94k on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 4 share grants and 18 option exercises.

The median purchase comes to €2,782. 2 out of 23 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The record was last updated on 4 August 2026 with an option exercise in Kiniksa Pharmaceuticals International, plc. The last purchase on record was published on 19 May 2025, which is 520 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.